Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20122543 | 0.91 | MME (0.33) | CYP1A2CYP2C9CYP2C19HTTMME | |
| SCHEMBL20122567 | 0.90 | MME (0.33) | MMEACEACE2 | |
| SCHEMBL20122377 | 0.89 | CYP1A2 (0.33) | CYP1A2CYP2C9CYP2C19HTTMME | |
| SCHEMBL20122568 | 0.88 | CYP1A2 (0.38) | CYP1A2CYP2C9CYP2C19HTTMME | |
| SCHEMBL20122586 | 0.87 | ACE (0.40) | MMEACEACE2 | |
| SCHEMBL20122401 | 0.86 | CYP1A2 (0.33) | CYP1A2CYP2C9CYP2C19HTT | |
| SCHEMBL20122570 | 0.86 | MME (0.31) | MMEACEACE2 | |
| SCHEMBL20122361 | 0.86 | MME (0.31) | MMEACEACE2 | |
| SCHEMBL20122366 | 0.82 | ACE (0.41) | MMEACEACE2 | |
| SCHEMBL20122571 | 0.81 | ACE (0.41) | CYP1A2CYP2C9CYP2C19MMEACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963428-B1 | Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use | Nguyen, Mark Quang (US) | 2018-05-08 | — | — | US | disclosed |